Mr. Brian Beck focuses on intellectual property and commercial litigation, with a particular focus on patent and trade secret litigation. He has advised clients and litigated cases involving medical devices, novel drug delivery systems, small molecules, and gene editing techniques. He has represented Cadila Healthcare Ltd.’s transdermal product subsidiary Zydus Noveltech in United States ANDA and trade secret litigation, among other foreign clients. He has also written extensively on Section 101 issues and argued Section 101 cases at the Federal Circuit and in district courts, including securing an early dismissal of a method of treatment patent for lack of patentable subject matter
